Recent developments in antibody derivatives against colorectal cancer; A review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent developments in antibody derivatives against colorectal cancer; A review
Authors
Keywords
Antibody derivatives, Colorectal cancer, Targeted therapy, Colorectal cancer markers
Journal
LIFE SCIENCES
Volume 265, Issue -, Pages 118791
Publisher
Elsevier BV
Online
2020-11-19
DOI
10.1016/j.lfs.2020.118791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM
- (2019) Jessica B. Casaletto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotherapy in colorectal cancer: rationale, challenges and potential
- (2019) Karuna Ganesh et al. Nature Reviews Gastroenterology & Hepatology
- VEGF in Signaling and Disease: Beyond Discovery and Development
- (2019) Rajendra S. Apte et al. CELL
- CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
- (2019) Reyes Gonzalez-Exposito et al. Journal for ImmunoTherapy of Cancer
- Immunotherapeutic Approaches for the Treatment of Colorectal Cancer
- (2019) E. V. Abakushina et al. BIOCHEMISTRY-MOSCOW
- Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy
- (2019) Davide Ciardiello et al. CANCER TREATMENT REVIEWS
- An examination of colorectal cancer burden by socioeconomic status: evidence from GLOBOCAN 2018
- (2019) Rajesh Sharma EPMA Journal
- Discovering therapeutic protein targets for muscle invasive bladder cancer by proteomic data analysis
- (2019) Samira Bahrami et al. Current Molecular Pharmacology
- A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
- (2018) Amita Patnaik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Frizzled Receptors as Potential Therapeutic Targets in Human Cancers
- (2018) Chui-Mian Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CD133: beyond a cancer stem cell biomarker
- (2018) Amir Barzegar Behrooz et al. JOURNAL OF DRUG TARGETING
- Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
- (2018) Yazhuo Zhang et al. Molecular Cancer
- Development of MGD007, a gpA33 x CD3 bispecific DART® protein for T-cell immunotherapy of metastatic colorectal cancer
- (2018) Paul A Moore et al. MOLECULAR CANCER THERAPEUTICS
- Effects of immuno-related gene polymorphisms on a bispecific antibody targeting colorectal cancer cell
- (2018) Cong-Min Zhang et al. Personalized Medicine
- Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers
- (2018) Aleksandra Borek et al. PLoS One
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors
- (2018) Antonio Jimeno et al. INVESTIGATIONAL NEW DRUGS
- Development of a tetravalent anti-GPA33/anti-CD3 bispecific antibody for colorectal cancers
- (2018) Zhihao Wu et al. MOLECULAR CANCER THERAPEUTICS
- Drug resistance and new therapies in colorectal cancer
- (2018) Kevin Van der Jeught et al. WORLD JOURNAL OF GASTROENTEROLOGY
- ISY1-1New development strategies of immunotherapy agents for colorectal cancer
- (2018) Josep Tabernero ANNALS OF ONCOLOGY
- Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells
- (2018) Fang-Rui Liu et al. BMC CANCER
- CD133 as a regulator of cancer metastasis through the cancer stem cells
- (2018) Geou-Yarh Liou INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Global trends in colorectal cancer mortality: projections to the year 2035
- (2018) Marzieh Araghi et al. INTERNATIONAL JOURNAL OF CANCER
- Overview of CD24 as a new molecular marker in ovarian cancer
- (2018) Vahideh Tarhriz et al. JOURNAL OF CELLULAR PHYSIOLOGY
- New therapies and insights into the changing landscape of colorectal cancer
- (2018) Scott Kopetz Nature Reviews Gastroenterology & Hepatology
- Identification of a novel single chain fragment variable antibody targeting CD24-expressing cancer cells
- (2017) Shirin Eyvazi et al. IMMUNOLOGY LETTERS
- Targeted cancer therapy through antibody fragments-decorated nanomedicines
- (2017) Abbas Alibakhshi et al. JOURNAL OF CONTROLLED RELEASE
- Isolation and characterization of anti c-met single chain fragment variable (scFv) antibodies
- (2017) Elmira Safaie Qamsari et al. Journal of Immunotoxicology
- Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer
- (2017) Sarah M. Cheal et al. JOURNAL OF NUCLEAR MEDICINE
- Potential mechanisms of CD133 in cancer stem cells
- (2017) Jae-Woo Jang et al. LIFE SCIENCES
- Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
- (2017) Pravin U. Dugel et al. OPHTHALMOLOGY
- Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies
- (2017) Alex Françoso et al. Drug Design Development and Therapy
- Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
- (2017) Wei Xia Ang et al. Oncotarget
- Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target
- (2017) Seyed Khalil Rashidi et al. Iranian Journal of Biotechnology
- Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models
- (2017) William K. Decker et al. Frontiers in Immunology
- Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors
- (2017) Katerina T. Xenaki et al. Frontiers in Immunology
- Periplasmic expression, purification, and characterization of an anti-epidermal growth factor receptor antibody fragment in Escherichia coli
- (2016) Won-Jae Chi et al. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
- Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates
- (2016) Carolin Sellmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker
- (2016) Joerg U Schmohl et al. MOLECULAR THERAPY
- Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR)
- (2016) Bahman Akbari et al. PROTEIN EXPRESSION AND PURIFICATION
- Role of targeted therapy in metastatic colorectal cancer
- (2016) Yoshihito Ohhara et al. World Journal of Gastrointestinal Oncology
- Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity 86Y- or 177Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates
- (2015) Sarah M. Cheal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer
- (2015) Sara Zalba et al. JOURNAL OF CONTROLLED RELEASE
- Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody
- (2015) Lei Zhao et al. JOURNAL OF IMMUNOTHERAPY
- Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells
- (2015) J. U. Schmohl et al. Targeted Oncology
- Cancer stem cells in progression of colorectal cancer
- (2015) Yujuan Zhou et al. Oncotarget
- Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts
- (2015) Jaime Tomé-Amat et al. SpringerPlus
- A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment
- (2014) Zahra Farajpour et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tests and investigations for colorectal cancer screening
- (2014) Magdalen R.R. Carroll et al. CLINICAL BIOCHEMISTRY
- Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool
- (2014) Marleen van Oosten et al. Translational Oncology
- Cancer stem cells in colorectal cancer from pathogenesis to therapy: Controversies and perspectives
- (2014) Caterina Fanali WORLD JOURNAL OF GASTROENTEROLOGY
- Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting
- (2013) J P Tiernan et al. BRITISH JOURNAL OF CANCER
- Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
- (2013) Daniel A. Vallera et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in action
- (2013) V. Heinemann et al. CANCER TREATMENT REVIEWS
- The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma
- (2013) Achim Rothe et al. INTERNATIONAL JOURNAL OF CANCER
- Progress in the identification of plasma biomarkers of colorectal cancer
- (2013) Caroline Coghlin et al. PROTEOMICS
- A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma
- (2013) Nate N. Waldron et al. Targeted Oncology
- Targeted therapies in colorectal cancer—an integrative view by PPPM
- (2013) Suzanne Hagan et al. EPMA Journal
- Production and characterization of scFvA33T1, an immunoRNase targeting colon cancer cells
- (2012) Jaime Tomé-Amat et al. FEBS Journal
- Activated leukocyte cell adhesion molecule (CD166)—Its prognostic power for colorectal cancer patients
- (2012) Michael Tachezy et al. JOURNAL OF SURGICAL RESEARCH
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- An overview of the c-MET signaling pathway
- (2011) Shawna Leslie Organ et al. Therapeutic Advances in Medical Oncology
- A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth
- (2010) Merete Thune Wiiger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review
- (2010) Jolien Tol et al. CLINICAL THERAPEUTICS
- Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins
- (2010) Shiran Shapira et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells
- (2010) Ines Herrmann et al. PLoS One
- Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
- (2009) T Osada et al. BRITISH JOURNAL OF CANCER
- Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA
- (2009) Ralf Lutterbuese et al. JOURNAL OF IMMUNOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now